S. E. Al-Batran, J. T. Hartmann, S. Probst, H. Schmalenberg, S. Hollerbach, R. Hofheinz, V. Rethwisch, G. Seipelt, N. Homann, G. Wilhelm, G. Schuch, J. Stoehlmacher, H. G. Derigs, S. Hegewisch-Becker, J. Grossmann, C. Pauligk, A. Atmaca, C. Bokemeyer, A. Knuth and E. J?ger, “Arbeitsgemeinschaft Internistische Onkologie. Phase III Trial in Metastatic Gastroesophageal Adeno- carcinoma with Fluorouracil, Leuco-Vorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgeme- inschaft Inter- nistische Onkologie,” Journal of Clinical Oncology, Vol. 26, 2008, pp. 1435-1442.

has been cited by the following article:

• TITLE: Microangiopathic Hemolytic Anemia and Diffuse Bone Metastasis by Signet Ring Cell Adenocarcinoma

  AUTHORS: Andrés J. Muñoz Martín, Pilar García Alfonso, María Carmen Riesco Martínez, Virginia Martínez Marín, Yolanda Jerez Gilarranz, Rebeca Mondejar Solís, Miguel Martín Jiménez

  KEYWORDS: Microangiopathic Haemolytic Anemia, Gastric Cancer, Paraneoplastic Syndrome, Chemotherapy, Signet Ring Cell Adenocarcinoma?

  JOURNAL NAME: Journal of Cancer Therapy, Vol.1 No.2, June 29, 2010

  ABSTRACT: Microangiopathic hemolytic anemia (MAHA) is a rare paraneoplastic syndrome and is typically associated with gastric adenocarcinoma. We report a 47-year-old woman who presented with asthenia, lower back pain and bleeding. Twelve years ago the patient underwent total gastrectomy due to gastric adenocarcinoma and achieved complete remission. The patient was diagnosed with MAHA and diffuses bone metastasis of signet ring cell adenocarcinoma of unknown origin and was treated successfully with polichemotherapy based on cisplatin and 5-fluorouracil.x